Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20050998HPVENSG00000122025.15protein_codingFLT3YesNo2322P36888
TVIS20065483HPVENSG00000122025.15protein_codingFLT3YesNo2322P36888
TVIS44031243HTLV-1ENSG00000122025.15protein_codingFLT3YesNo2322P36888
TVIS44008044HTLV-1ENSG00000122025.15protein_codingFLT3YesNo2322P36888
TVIS44020668HTLV-1ENSG00000122025.15protein_codingFLT3YesNo2322P36888
TVIS44036283HTLV-1ENSG00000122025.15protein_codingFLT3YesNo2322P36888
TCGA Plot Options
Drug Information
GeneFLT3
DrugBank IDDB06595
Drug NameMidostaurin
Target IDBE0000147
UniProt IDP36888
Regulation Typeantagonist
PubMed IDs16969355; 27186148
CitationsMillward MJ, House C, Bowtell D, Webster L, Olver IN, Gore M, Copeman M, Lynch K, Yap A, Wang Y, Cohen PS, Zalcberg J: The multikinase inhibitor midostaurin (PKC412A) lacks activity in metastatic melanoma: a phase IIA clinical and biologic study. Br J Cancer. 2006 Oct 9;95(7):829-34. Epub 2006 Sep 12.@@Gallogly MM, Lazarus HM: Midostaurin: an emerging treatment for acute myeloid leukemia patients. J Blood Med. 2016 Apr 19;7:73-83. doi: 10.2147/JBM.S100283. eCollection 2016.
GroupsApproved; Investigational
Direct ClassificationIndolocarbazoles
SMILESCO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O)N(C)C(=O)C1=CC=CC=C1
Pathways
PharmGKB
ChEMBLCHEMBL608533